Muscat: The Ministry of Health, represented by the Drug Safety Centre, has introduced a comprehensive set of regulations to govern the advertisement and definition of pharmaceutical products.
These regulations are aimed at ensuring the safe promotion of medications and protecting public health by establishing strict licensing procedures and content requirements.
The new framework specifies that advertisements must only be made after securing prior written approval from the designated authority and must not be altered or re-used without explicit permission.
Furthermore, only licensed pharmacists are allowed to promote pharmaceutical products, and such advertising must not be carried out through unqualified individuals.
Licenses are valid for a renewable period of two years, and applicants must submit renewal requests at least 30 days before expiry.
Delays in submitting the required documents or renewal requests may result in refusal or cancellation of the license.
The law also authorises the centre to suspend any advertising license if there is evidence of harm or misleading outcomes associated with the promoted drug.
Applicants whose requests are denied have the right to file an appeal within 60 days of notification.
In terms of application procedures, drug advertising licenses must be accompanied by relevant documents, including drug registration certificates, proof of payment, and advertising content that aligns with the drug’s approved medical summary.
Oman Observer is now on the WhatsApp channel. Click here
